Vestibular pathways involved in cognition | Frontiers in Integrative Neuroscience | 2014 | 161 |
AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition | Gut | 2014 | 149 |
Ubiquitin-proteasome system and hereditary cardiomyopathies | Journal of Molecular and Cellular Cardiology | 2014 | 59 |
Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease | Antimicrobial Agents and Chemotherapy | 2014 | 50 |
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? | Nephrology Dialysis Transplantation | 2014 | 41 |
Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease | Parkinsonism and Related Disorders | 2014 | 36 |
PrP(C) from stem cells to cancer | Frontiers in Cell and Developmental Biology | 2014 | 35 |
Baclofen-induced manic symptoms: case report and systematic review | Psychosomatics | 2014 | 32 |
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age | Antimicrobial Agents and Chemotherapy | 2014 | 31 |
Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors | FASEB Journal | 2014 | 31 |
Optimization of irinotecan chronotherapy with P-glycoprotein inhibition | Toxicology and Applied Pharmacology | 2014 | 30 |
Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometry | Journal of Pharmaceutical and Biomedical Analysis | 2014 | 29 |
Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals | FASEB Journal | 2014 | 27 |
Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokinetics | CPT: Pharmacometrics and Systems Pharmacology | 2014 | 18 |
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence? | Diabetes and Metabolism | 2014 | 17 |
Vestibular loss promotes procedural response during a spatial task in rats | Hippocampus | 2014 | 16 |
Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children | British Journal of Clinical Pharmacology | 2014 | 16 |
Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke | Proteome Science | 2014 | 13 |
AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1 | Fundamental and Clinical Pharmacology | 2014 | 13 |
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial | Antiviral Therapy | 2014 | 13 |
Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients | PLoS ONE | 2014 | 13 |
Use of very-high-dose olanzapine in treatment-resistant schizophrenia | Schizophrenia Research | 2014 | 12 |
Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer | International Journal of Gynecological Cancer | 2014 | 9 |
Microclimate next to the skin: influence on percutaneous absorption of caffeine (ex-vivo study) | Skin Research and Technology | 2014 | 8 |
Susceptibility of extended-spectrum- β-lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages | Journal of Antimicrobial Chemotherapy | 2014 | 7 |